Yahoo Web Search

Search results

  1. People also ask

  2. 4 days ago · Avalo Therapeutics Stock (NASDAQ:AVTX) Dividends: History, Yield and Dates. December 29, 2023 | marketbeat.com. Trading was temporarily halted for "AVTX" at 07:12 PM with a stated reason of "News pending." December 27, 2023 | msn.com. Avalo Therapeutics announces a 1-for-240 reverse stock split.

    • 345 N Reid Place, Suite 620, Sioux Falls, 57103, SD
    • contact@marketbeat.com
    • (844) 978-6257
  3. Dec 27, 2023 · Avalo Therapeutics, a biotech company developing therapies for immune dysregulation, announced a 1-for-240 reverse stock split effective on December 28, 2023. The reverse split was intended to increase the per share price and regain compliance with Nasdaq listing requirements.

  4. Find the latest Avalo Therapeutics, Inc. (AVTX) stock quote, history, news and other vital information to help you with your stock trading and investing.

  5. Jun 26, 2023 · AVTX-002, a drug for asthma, failed to meet its primary endpoint in a Phase 2 trial. The company identified a positive trend in a subpopulation of patients with high baseline LIGHT levels, a potential biomarker for treatment.

  6. Sep 22, 2023 · shares are trading higher Friday. The stock appears to be recovering from a 25% drop on Thursday. What To Know: Shares of AVTX have been volatile recently after the company announced the sale...

  7. View Avalo Therapeutics Inc AVTX stock quote prices, financial information, real-time forecasts, and company news from CNN.

  8. 5 days ago · Avalo Therapeutics (AVTX) is a biotech company that develops treatments for inflammatory and autoimmune diseases. The stock price has been declining since February 2024, possibly due to weak financial results, reverse stock split, and divestiture of assets.

  1. People also search for